ExitOdds Method

Ranking · Summer 2021 · Healthcare · Diagnostics

Digistain

Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow

3.4%

odds of being acquired in the next two years

0.5× the average (6.8%)

#4264 of 4,339 active YC companies · top 99%

Team of 40 · London, England, United Kingdom

Raises the odds

Nothing stands out.

Lowers the odds

↓ industry: Healthcare

↓ sector: Diagnostics

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Digistain's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub